Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib pharmacokinetics and pharmacogenetics in children with hematological malignancy undergoing lumbar punctures
ISRCTN07429476Phase 4Completed
- Sponsor
- CHEO Research Institute
- Start
- Apr 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of celecoxib in hematopoietic malignancies, sponsored by CHEO Research Institute. Primary endpoints: Mean total and unbound plasma celecoxib concentration in all patients and Group 1, Mean CSF celecoxib concentration in Group 1 and 6 more. Started Apr 2009; status: completed.
02
Drugs
celecoxib
03
Conditions
hematopoietic malignancies
Beyond the preview
Go deeper on ISRCTN07429476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN07429476.